: Unlike conventional MHC class I and class II molecules, CD1 proteins present lipid or glycolipid antigens to T cells. Group 1 CD1 proteins present microbial lipid antigens to diverse T cells, thereby significantly expanding the ability of the adaptive immune system to recognize and respond to pathogens. The group 2 CD1 proteins however, do not interact with diverse T cells and have instead been shown to interact with a unique subset of T cells, the NKT cells. Upon activation, NKT cells promptly secrete large amounts of cytokines, which may both link and regulate innate and adaptive immunity. The unique features of CD1, which lead to the selection, and activation of these CD1-restricted T cells remain largely unknown. This proposal seeks to examine the effects of CD1 expression levels and tissue distribution on the development of CD1-restricted T cells which will determine if novel or conventional mechanisms govern the selection of this unique population of T cells. First, we will use transgenic mice that express high levels of CD1 to examine how CD1 surface density affects the outcomes of NKT cell development. We will also attempt to purify ligands that associate with CD1 from the thymus and spleen of CD1 transgenic mice to determine if tissue-specific ligands exist as the ligands involved in this selection and activation still remain unknown. Secondly, two lines of the CD1 congenic mice, expressing CD1 allele derived from M. castaneus and M. spretus, will be used to study the effect of CD1 polymorphism on antigen presentation and T cell development. In addition, the frequencies and TCR repertoire of the alloreactive CD1-restricted T cells in response to skin graft from CD1-congenic mice will be determined.
A final aim i s to examine the molecular mechanisms that regulate the unique expression of CD1 which are likely to be important for the selection/development of NKT cells. We will characterize the promoter region of mCD1.1 and mCD1.2 to identify regulatory elements that are involved in the constitutive and tissue-specific expression of CD1. Collectively, these studies will provide new insight into which characteristic of CD1 contributes to its unique capacity to select and activate NKT cells. These studies may lead to novel ways to manipulate the immune response mediated by CD1-restricted T cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043407-08
Application #
6927104
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Miller, Lara R
Project Start
1998-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
8
Fiscal Year
2005
Total Cost
$299,960
Indirect Cost
Name
University of Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Bagchi, Sreya; Genardi, Samantha; Wang, Chyung-Ru (2018) Linking CD1-Restricted T Cells With Autoimmunity and Dyslipidemia: Lipid Levels Matter. Front Immunol 9:1616
Weng, Xiufang; He, Ying; Visvabharathy, Lavanya et al. (2017) Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease. J Hepatol 67:791-800
Wang, Yajun; Yun, Chawon; Gao, Beixue et al. (2017) The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep 20:600-612
O'Hagan, Kyle L; Zhao, Jie; Pryshchep, Olga et al. (2015) Pak2 Controls Acquisition of NKT Cell Fate by Regulating Expression of the Transcription Factors PLZF and Egr2. J Immunol 195:5272-84
Siddiqui, Sarah; Visvabharathy, Lavanya; Wang, Chyung-Ru (2015) Role of Group 1 CD1-Restricted T Cells in Infectious Disease. Front Immunol 6:337
Zhao, Jie; Weng, Xiufang; Bagchi, Sreya et al. (2014) Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc Natl Acad Sci U S A 111:2674-9
Weng, Xiufang; Liao, Chia-Min; Bagchi, Sreya et al. (2014) The adaptor protein SAP regulates type II NKT-cell development, cytokine production, and cytotoxicity against lymphoma. Eur J Immunol 44:3646-57
Zhao, Jie; Bagchi, Sreya; Wang, Chyung-Ru (2014) Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides. Oncoimmunology 3:e28977
Liao, Chia-Min; Zimmer, Michael I; Wang, Chyung-Ru (2013) The functions of type I and type II natural killer T cells in inflammatory bowel diseases. Inflamm Bowel Dis 19:1330-8
Liao, Chia-Min; Zimmer, Michael I; Shanmuganad, Sharmila et al. (2012) dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology 142:326-34.e1-2

Showing the most recent 10 out of 31 publications